期刊文献+

不同毒力疟原虫感染早期根治性治疗对再感染体液免疫应答的影响

Effect of Radical Cure in Early Phase of Primary Infection with Different Virulent Plasmodia on Humoral Immune Response to Homologous Reinfection
下载PDF
导出
摘要 为探讨不同毒力疟原虫感染早期根治性治疗对再感染体液免疫应答的影响,用致死型和非致死型约氏疟原虫感染DBA/2小鼠,感染后3 d进行根治性治疗,并于初次感染后90 d进行再感染。计数红细胞感染率和检测再感染前(0 d)和再感染后(1、3、5 d)不同时间点脾细胞中活化性B细胞百分率以及血清中IgG、IgG1和IgG2 a水平,结果显示,再感染后2组小鼠均出现短暂的低水平虫体血症,再感染后第3天活化性B细胞、IgG、IgG1和IgG2 a均出现有意义的升高,但在每一相同检测时间点,2组小鼠的虫体血症、活化性B细胞百分率、IgG、IgG1和IgG2 a水平均没有显著差异。这些结果表明,不同毒力疟原虫感染早期的根治性治疗并不影响宿主在再感染时产生有效的体液免疫应答,强毒株原虫感染也能获得与弱毒株相同的可抵御再感染的能力。 In order to investigate the effect of radical cure in early phase of primary infection with different virulent plasmodia(Vp) on humoral immune response to homologous reinfection,DBA/2 mice were infected respectively with P.y17XL and P.y17XNL parasited erythrocytes,and radically cured on 3 d after infection.The mice were reinfected respectively with P.y17XL and P.y17XNL on 90 d after primary infection,then the level of parasitemia and specific IgG,IgG1 and IgG2a in sera as well as percentage of activated B cells in spleen cells were observed.The results showed that parasitemia in post-reinfection mice was transient and extremely low,and the percentage of activated B cells,specific IgG,IgG1 and IgG2a in these mice began to increase on 3 d of post-reinfection,however,in each testing time point the levels of parasitemia,IgG,IgG1 and IgG2a as well as the percentage of activated B cells from two groups of mice were not significantly different.These results suggested that radical cure in early phase of primary infection with different Vp had less effect on humoral immune response to homologous reinfection,Vp infection,being similar to low Vp infection,could also get the ability to resist reinfection.
出处 《微生物学杂志》 CAS CSCD 2011年第1期102-105,共4页 Journal of Microbiology
关键词 不同毒力疟原虫 根治性治疗 再感染 体液免疫应答 different virulent plasmodia radical cure reinfection humoral immune response
  • 相关文献

参考文献8

  • 1Michon P, Cole-Tobian JL, Dabod E,et al. The risk of malarialinfections and disease in Papua New Guinean children[ J]. Am J Trop Med Hyg,2007,76(6) :997-1008.
  • 2Reiling L, Riehards JS, Fowkes FJ, et al. Evidence that theerythroeyte invasion ligand PfRh2 is a target of protective immu-nity against Plasmodium falclparum malaria [ J ]. J Immunol,2010,185 (10) :6157-6167.
  • 3Schaecher K, Kumar S, Yadava A, et al. Genome-wide expres- sion profiling in malaria infection reveals transcriptional changesassociated with lethal and nonlethal outcomes [ J]. Infect Im- mun,2005,73 (9) :6091-6100.
  • 4Collins WE, Jeffery GM, Roberts JM. A retrospective examina- tion of reinfection of humans with Plasmodium vivax[ J]. Am J Trop Med Hyg,2004,70(6):642-644.
  • 5Collins WE,Jeffery GM. A retrospective examination of second- ary sporozoite- and trophozoite-induced infections with Plasmo-dium falciparum: development of parasitologic and clinical im- munity following secondary infection[J]. Am J Trop Med Hyg,1999,61 ( 1 Suppl) :20-35.
  • 6Wipasa J, Hemsokana P, Ruankham T, et al. Investigation ofmemory responses following Plasmodium chabaudi AS infectionin mice distinct in susceptibility to clinical malaria[ J]. Parasi-tol Res, 2009,106 ( 1 ) : 283-287.
  • 7Pombo DJ, Lawrence G, Hirunpetcharat C, et al. Immunity tomalaria after administration of ultra-low doses of red cells infec- ted with Plasmodium falciparum [ J ]. Lancet, 2002, 360 (9333) :610-617.
  • 8Freitas do Rosdfio AP,Muxel SM. Gradual decline in malaria- specific memory T cell responses leads to failure to maintainlong-term protective immunity to Plasmodium chabaudi AS de- spite persistence of B cell memory and circulating antibody[ J]. J Immuno1,200g, 181 ( 12 ) :8344-8355.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部